- Source: UK-414,495
UK-414,495 is a drug developed by Pfizer for the treatment of female sexual arousal disorder. UK-414,495 acts as a potent, selective inhibitor of the enzyme neutral endopeptidase, which normally serves to break down the neuropeptide VIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation.
See also
ABT-670
ABT-724
Bremelanotide
Cabergoline
Flibanserin
Testosterone (patch)
Melanotan II
Pramipexole
PF-219,061
S-17092
Tibolone